<DOC>
	<DOC>NCT00872196</DOC>
	<brief_summary>This is a follow-up study with no treatment and only samples being collected.</brief_summary>
	<brief_title>A Follow-up Study to Assess Resistance to ABT-072 in HCV-infected Subjects Administered ABT-072 in Prior ABT-072 Studies</brief_title>
	<detailed_description>The purpose of this study is to evaluate the development of specific viral mutations in response to treatment with ABT-072.</detailed_description>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<criteria>Main Selection Criteria: A subject that has received either ABT072 or placebo in a prior study involving ABT072. The investigator considers the subject unsuitable for the study for any reasons inclusive of, but not limited to, failure to comply with study procedures in a prior ABT072 clinical study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>